{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T06:25:37Z","timestamp":1766471137051,"version":"3.48.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,22]]},"DOI":"10.7759\/cureus.99889","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T06:23:35Z","timestamp":1766471015000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive Supranuclear Palsy With Post-traumatic Frontal Lobe Damage Mimicking Anti-IgLON5 Antibody Disease"],"prefix":"10.7759","author":[{"given":"Damla","family":"Ates Gulkok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiswarya","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakira","family":"Mishan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Zaita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Fekete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200353","article-title":"Anti-IgLON5 disease 10 years later: what we know and what we do not know","volume":"12","author":"Graus F","year":"2025","unstructured":"Graus F, Sabater L, Gaig C, Gelpi E, Iranzo A, Dalmau JO, Santamaria J. Anti-IgLON5 disease 10 years later: what we know and what we do not know. Neurol Neuroimmunol Neuroinflamm. 2025, 12:e200353. 10.1212\/NXI.0000000000200353","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02805-y","article-title":"Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy","volume":"148","author":"Gelpi E","year":"2024","unstructured":"Gelpi E, Reinecke R, Gaig C, et al.. Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy. Acta Neuropathol. 2024, 148:53. 10.1007\/s00401-024-02805-y","journal-title":"Acta Neuropathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-7794938\/v1","article-title":"Progressive supranuclear palsy with post-traumatic frontal lobe damage mimicking anti-IgLON5 antibody disease [preprint]","author":"Ates-Gulkok D","year":"2025","unstructured":"Ates-Gulkok D, Raj A, Mishan Y, et al.. Progressive supranuclear palsy with post-traumatic frontal lobe damage mimicking anti-IgLON5 antibody disease [preprint]. Res Sq. 2025, 10.21203\/rs.3.rs-7794938\/v1","journal-title":"Res Sq"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.46871\/eams.1322881","article-title":"The \u201ceye of the tiger sign\u201d in progressive supranuclear palsy: is it a coincidence or not?","volume":"4","author":"Gen\u00e7 H","year":"2024","unstructured":"Gen\u00e7 H, \u00d6ks\u00fcz N, Do\u011fu O. The \u201ceye of the tiger sign\u201d in progressive supranuclear palsy: is it a coincidence or not?. Exp Appl Med Sci. 2024, 4:595-600. 10.46871\/eams.1322881","journal-title":"Exp Appl Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.852215","article-title":"Anti-IgLON5 disease - the current state of knowledge and further perspectives","volume":"13","author":"Madetko N","year":"2022","unstructured":"Madetko N, Marzec W, Kowalska A, Przewodowska D, Alster P, Koziorowski D. Anti-IgLON5 disease - the current state of knowledge and further perspectives. Front Immunol. 2022, 13:852215. 10.3389\/fimmu.2022.852215","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8310","article-title":"The psychiatric symptoms in anti-IgLON5 disease: case report and literature review","volume":"12","author":"Luo Y","year":"2024","unstructured":"Luo Y, Xiao J, Li J. The psychiatric symptoms in anti-IgLON5 disease: case report and literature review. Clin Case Rep. 2024, 12:e8310. 10.1002\/ccr3.8310","journal-title":"Clin Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.753856","article-title":"Ocular motor abnormalities in anti-IgLON5 disease","volume":"12","author":"Macher S","year":"2021","unstructured":"Macher S, Milenkovic I, Zrzavy T, et al.. Ocular motor abnormalities in anti-IgLON5 disease. Front Immunol. 2021, 12:753856. 10.3389\/fimmu.2021.753856","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428333-progressive-supranuclear-palsy-with-post-traumatic-frontal-lobe-damage-mimicking-anti-iglon5-antibody-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T06:23:36Z","timestamp":1766471016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428333-progressive-supranuclear-palsy-with-post-traumatic-frontal-lobe-damage-mimicking-anti-iglon5-antibody-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.99889","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,22]]}}}